bioRxivGenomicsPreprint
Interactions Between Dietary Metabolites and Regulatory Risk Variants for Human Colon Cancer
Tania FaboiD, Robin M. MeyersiD, Evin M. PadhiiD, Laura N. KellmaniD, Yang ZhaoiD, Soumya KunduiD, David L. ReynoldsiD, Ziwei CheniD, Xue YangiD, Lisa A. KoiD, Ibtihal ElfakiiD, Stephen B. MontgomeryiD, Paul A. KhavariiD
Abstract
Interactions between genetic variants and environmental factors influence malignancy risk, including for colorectal cancer (CRC). Prevalent CRC susceptibility loci reside predominantly in noncoding regulatory DNA where they may interact with dietary influences to dysregulate expression of specific genes predisposing to neoplasia. The impacts of CRC protective and risk dietary metabolites, butyrate and deoxycholic acid, were thus studied on the transcription-directing activity of 3703 regulatory CRC-associated variants via massively parallel reporter assays (MPRA) in human colonic cells. 1595 variant-dietary metabolite interactions were identified, pointing to dysregulation of MED13L, NKD2, and several modulators of Wnt/{beta}-catenin signaling in potential CRC gene-environment interactions (GxE). Opposing impacts of butyrate and deoxycholic acid were also uncovered, indicating dietary influences may converge on common CRC risk loci and nominating FOSL1 and SP1 as mediators of these opposing responses. Coupling MPRA to relevant environmental factors offers an approach to extend insight into GxE in common human cancers.
- organism: human
- assay: DNA methylation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Intake of red and processed meat, use of non-steroid anti-inflammatory drugs, genetic variants and risk of colorectal cancer; a prospective study of the Danish \"Diet, Cancer and Health\" cohort
Vibeke Charlotte Andersen, Ulrich Halekoh, … Tine Iskov Kopp·International Journal of Molecular SciencesPeer-reviewed·Mar 5, 2019
- Gut microbiota composition in colorectal cancer patients is genetically regulated
Francesca Colombo, Oscar Illescas, … Manuela Gariboldi·Scientific ReportsPeer-reviewed·Jul 6, 2022
- Genetic Variation at 19q13.33 confers colorectal cancer risk through the interaction of mucosal expression of FUT2 and plasma vitamin B12 levels
Morven Allan, Vidya Rajasekaran, … Malcolm G. Dunlop·medRxiv·Jul 14, 2026
- Colorectal cancer risk in bowel adenomas based on lifestyle exposures, tissue preconditioning and DNA methylation
J. Sutton, M. Moorghen, … A. Lorincz·bioRxiv·Aug 26, 2021
- Sulfidogenic Bacteria and the Risk of Colorectal Cancer
Darren Lee, Nicholas Jay Ollberding, … Jordan R. Kharofa·bioRxiv·Jul 16, 2026
- Genotype and methylation interact to reconfigure transcriptional regulation in colorectal cancer
Byounghun Kim, Hanbeen Kim, … Sun Shim Choi·bioRxiv·May 30, 2026